Clinical Deterioration, Vital Sign
Conditions
Brief summary
The current pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs in this patient group.
Detailed description
The healthcare system is challenged by an aging patient population with chronic diseases, and acute admissions must be housed in hospitals with fewer beds and less staff resources. This increases the need for earlier discharge and for treatment shifted to the patients' own home. Furthermore, the transition from the hospital to the home setting is one of potential hazard, due to the lack of observation and intervention possibilities. This pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs i in the patients' own homes during the first days after discharge.
Interventions
DEVICEContinuously monitoring
Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge. Monitoring will last for a maximum of eight days.
Sponsors
Technical University of Denmark
University Hospital Bispebjerg and Frederiksberg
Rigshospitalet, Denmark
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Adult patients (≥18 years) Admitted with an acute medical disease and scheduled for discharge to their own homes within five days from inclusion.
Exclusion criteria
* Allergy to plaster, plastic, or silicone. * A pacemaker or Implantable Cardioverter Defibrillator (ICD) device. * If the patient was deemed not able to open the front door when visited by the investigator. * Inability to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of data collection from the Lifetouch patch | Up to 8 days of monitoring |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Duration of complete peripheral saturation data | Up to 8 days of monitoring | — |
| Duration of complete blood pressure data | Up to 8 days of monitoring | — |
| Cummulated duration of desaturation | Up to 8 days of monitoring | Peripheral saturation below 88% and 85% |
| Number of events with SpO2 < 85% in at least 5 consecutive minutes | Up to 8 days of monitoring | — |
| Number of deviating vital parameters in accordance to defined microevents | Up to 8 days of monitoring | — |
| Number of events with SpO2 < 88% in at least 10 consecutive minutes | Up to 8 days of monitoring | — |
Other
| Measure | Time frame |
|---|---|
| Re-admission and cause of re-admission within 30-days | 30-days follow up |
Countries
Denmark
Outcome results
None listed